WestEnd Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
LMFP
HGIM
DC
CF
MIHAS
WestEnd Advisors's ELV Position: Q2 2026 in Review
WestEnd Advisors held its Elevance Health (ELV) position steady in Q2 2026 at 6 shares worth $2.32K. The position accounts for ﹤0.01% of the portfolio, ranked #175.
WestEnd Advisors first reported a position in ELV in Q4 2021 and has held it in 16 quarters since. The position peaked at $3.92K in Q1 2025. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- WestEnd Advisors held 6 shares of Elevance Health worth $2.32K as of Q2 2026.
- WestEnd Advisors left its Elevance Health share count unchanged in Q2 2026.
- Elevance Health made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #175 holding.
- WestEnd Advisors first reported a position in Elevance Health in Q4 2021 and has held it in 16 quarters since.
- WestEnd Advisors's Elevance Health position peaked at $3.92K in Q1 2025.
- 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.